CTLA-4 has been detected on tumor infiltrating NK cells in mice but has yet to be looked at in humans so further studies are needed to assess the benefit of combined CTLA-4 blockade and NK cell-based therapy (94). This evidence concerns the gene CTLA4 and neoplasm.